Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
Welcome to the MHH
Searched for gene. Found 167 results in 4 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • »
News

MHH: 1.5 million euros for rapid therapies against viral diseases

Relevance: 73%
 

so-called RNA interference (RNAi). RNAi is a natural mechanism in our cells for the targeted silencing of genes. In the process, the so-called messenger RNAs (mRNAs) are cleaved and the building instructions for [...] so-called in-silico design, the research team has primarily searched for "conserved" regions from gene databases. These are indispensable for the virus and are therefore unlikely to change, so that no

Page

Research

Relevance: 73%
 

city to improve graft survival after allogeneic or xenogeneic transplantation. Advanced gene regulatory and gene editing approaches, ex situ perfusion as well as tissue and organ engineering strategies

Page

Year 2013

Relevance: 73%
 

Dr. Schambach / Dr. Adrian Schwarzer, Experimental Hematology, OE 6960, project: Using inducible gene expression and RNAi to investigate murine models of acute T-cell leukemia in vivo Final exam November [...] Pediatric Pneumology, OE 6710, project: Functional analysis of regulatory variants of modifying genes that determine the outcome of the monogenic disease cystic fibrosis Final exam November 2016. Nurullah

Page

Dr. rer. nat. Jörg Mengwasser

Relevance: 73%
 

biochemical and molecular biology assays like IF, IHC, WB, ELISA, cytokine multiplexing, qPCR, cloning and gene and tissue microarrays. https://orcid.org/0000-0002-2959-4098

Page

4th International GSCN Annual Conference

Relevance: 73%
 

topics, including reprogramming, regenerative therapies, hematopoietic stem cells, drug development and gene therapy, to name but a few. The conference participants, over 400 in total, had ample opportunity

News

2.5 million euros for rapid therapies against viral diseases

Relevance: 72%
 

multiplying and spreading in the body. RNAi is a natural mechanism in our cells for switching off genes in a targeted manner. In the process, the so-called messenger RNAs are cleaved and the instructions [...] With the help of artificial intelligence, so-called in-silico design, the research team searched gene databases primarily for "conserved" regions. These are essential for the virus and are therefore unlikely

Page

Year 2007

Relevance: 72%
 

Klein, Pediatric Hematology and Oncology, OE 6780, project: The use of morpholino based knockdown gene technology as well as genetic studies to determine the function of HAX1 in zebrafish Final exam November [...] mouse models of leukemia; 2.Mechanisms of induction of immunologic tolerance by leukemic cells; 3.Gene therapy for hematologic disorders Final exam November 2012 Theodros Solomon Tsegaye (MD) ETHIOPIA

Page

Year 2005

Relevance: 72%
 

supervisor: Prof. Dr. Rudolph, now University of Ulm project: Analysis of the role of stanniocalcins genes and apoptosis pathways during cellular and organismal ageing Final exam June 2009 Lydia Asrat Haile [...] INDIA supervisor: Prof. Dr. Kispert, Molecular Biology, OE 5250, project: Functional analysis of Tbx gene in heart development Final exam November 2009 Inga Sörensen-Zender GERMANY supervisor: Prof. Dr. Gossler

Page

Year 2009

Relevance: 72%
 

Ramesh Pandey (Vet.) INDIA superrvisor: Prof. Dr. Kabesch, Paediatric Pneumology, project: TLR pathway genes and susceptibility for allergy and atopic diseases Final exam January 2013 Ruhi Phaltane INDIA supervisor: [...] project: Humanized models to assess the genotoxicity of viral vectors in the context of hematopoietic gene therapy and in vivo selection Final exam November 2013. Georgios Sogkas GREECE supervisor: Prof. Dr

Page

News

Relevance: 72%
 

ion and scaling, as well as data analysis, including cell clustering, differential gene expression analysis, and gene enrichment analysis. The workflow generates a report in html format, and contains several

  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • »
Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen